A high-integrity R&D program pairs product experimentation with clinical governance: psychiatry, psychology, primary care, nursing, pharmacy, data science, legal/privacy, security and patient-experience representation all review new features before they touch care. The governance committee maintains an inventory of clinical content and algorithms, documents rationale for changes, and defines approval levels for pilot versus broad deployments. Research should be separated from routine care and use appropriate ethics review when human subjects are involved.
Validation requirements are proportionate to risk: usability testing for low-risk features, and rigorous calibration, subgroup analysis and outcome assessment for clinical or predictive models. Post-release, dashboards track safety events, clinician overrides, unresolved alerts and model drift. This structure intends to make innovation repeatable, auditable and aligned with professional standards while protecting patient safety and trust.
